Theranostic probes

Research output: Contribution to journalArticle

Abstract

Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

Original languageEnglish
Pages (from-to)386-391
Number of pages6
JournalDrug Delivery System
Volume26
Issue number4
DOIs
Publication statusPublished - Oct 31 2011
Externally publishedYes

Fingerprint

Therapeutic Uses
Single-Photon Emission-Computed Tomography
Toxicology
Contrast Media
Pharmacokinetics
Technology
Theranostic Nanomedicine
Therapeutics

Keywords

  • Contrast medium
  • Imaging
  • NanoDDS

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Theranostic probes. / Kano, Mitsunobu.

In: Drug Delivery System, Vol. 26, No. 4, 31.10.2011, p. 386-391.

Research output: Contribution to journalArticle

Kano, Mitsunobu. / Theranostic probes. In: Drug Delivery System. 2011 ; Vol. 26, No. 4. pp. 386-391.
@article{4a281985dcc147e0afa8556fe5bc8e67,
title = "Theranostic probes",
abstract = "Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.",
keywords = "Contrast medium, Imaging, NanoDDS",
author = "Mitsunobu Kano",
year = "2011",
month = "10",
day = "31",
doi = "10.2745/dds.26.386",
language = "English",
volume = "26",
pages = "386--391",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "4",

}

TY - JOUR

T1 - Theranostic probes

AU - Kano, Mitsunobu

PY - 2011/10/31

Y1 - 2011/10/31

N2 - Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

AB - Prediction of therapeutic effect in a patient is difficult. NanoDDS technology may enable this, by incorporating both diagnostic and therapeutic function on a nanodevice. Such nanodevices are called as theranostic probes. Contrast media for various clinical imaging modalities(CT, MRI, US, PET, or SPECT)are the key to realize diagnostic function in theranostic probes. Further studies needed, however, before clinical application of theranostic probes, including toxicology, pharmacokinetics, and other aspects.

KW - Contrast medium

KW - Imaging

KW - NanoDDS

UR - http://www.scopus.com/inward/record.url?scp=80055114986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055114986&partnerID=8YFLogxK

U2 - 10.2745/dds.26.386

DO - 10.2745/dds.26.386

M3 - Article

VL - 26

SP - 386

EP - 391

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 4

ER -